Navigation Links
FastMed Urgent Care and MedVantx Offer Consumers First Ever Access to Free Samples of Medications through an Automated Medication Cabinet Across North Carolina's Largest Network of Urgent Care Centers
Date:3/6/2013

SAN DIEGO and CLAYTON, N.C., March 6, 2013 /PRNewswire/ -- MedVantx, Inc. and FastMed Urgent Care, P.C., the largest network of urgent care centers in North Carolina, today announced they have partnered to provide patients the option of receiving free, full course samples of generic prescription and over-the-counter medications at the point-of-care (POC) in FastMed clinics. The MedVantx MedStart™ Connect Program will be offered in all 30 FastMed urgent care centers in North Carolina and all future North Carolina FastMed urgent care centers.The MedStart Connect program begins with samples provided by the prescriber directly to the patient through the proprietary automated "ATM-like" medication management system, the MedStart™ cabinet, which is in each FastMed clinic.  The MedStart Connect program supports patients and helps ensure they are taking their medications properly by, upon receipt of authorization, calling them shortly after their FastMed visit to remind them to refill their chronic prescriptions via either a retail pharmacy or an optional home delivery program. A recent study by the New England Healthcare Institute estimated that $290 billion, or 13% of all U.S. healthcare costs are attributable to medication non-adherence.

"We are pleased to provide patients in North Carolina with full course sample medication options at our urgent care centers through our partnership with MedVantx. The convenience and availability of these full course sample medications at the point-of-care, right in our FastMed clinics, will help promote medication compliance and better health care outcomes for our patients," said Jason A. Williams MPAS, Ph.D., President and CEO of the Eastern Region and Founder of FastMed.

"MedVantx is focused on eliminating gaps in primary medication adherence by ensuring patients get the proper medication in hand at the point-of-care and that they remain on that therapy over time through an integrated, convenient and cost-effective home delivery platform," said Rob Feeney , MedVantx CEO and Founder. "Our program is particularly well suited to the urgent care setting, where immediate access to appropriate medication is critical to begin the healing process and follow-up ensures continued health."About MedVantx, Inc. MedVantx is an innovative medication management and delivery company committed to streamlining access, reducing healthcare costs, increasing medication adherence, and enhancing patient satisfaction while improving patient quality of care and outcomes.  The MedStart Connect program provides for a fully-automated, integrated, point-of-care to consumer home delivery channel focused on increasing the quality and cost effectiveness of the last non-managed pharmaceutical channel – the physician office sample closet.  MedStart Connect includes free initial therapy samples of prescription and over-the-counter medication at the point of care, a consumer helpline providing drug information, adherence management services, and convenient consumer home delivery through its mail order pharmacy.  The national MedVantx network has served over 3.5 million consumers through an integrated network including health plans, manufacturers and more than 3,500 prescribers in diverse care settings. Visit us at www.medvantx.com.About FastMed Urgent Care, P.C.FastMed Urgent Care is a North Carolina-based owner and operator of urgent care facilities with locations throughout North Carolina and Arizona.  FastMed focuses on the delivery of non-appointment based medicine to the non-emergency patient market. The urgent care centers are open 365 days a year and are staffed with experienced and licensed physicians, physician assistants and nurse practitioners. For more information, please visit www.fastmed.com. FastMed is managed by an affiliated entity of one of the investment funds of the Comvest Group.

About the Comvest GroupThe Comvest Group, with $1.2 billion of assets under management, provides flexible financing solutions to lower middle-market companies through its equity and debt funds, often meeting time-critical and complex funding requirements.  The firm includes seasoned, senior level operating executives who partner with managers and owners of companies to operationally improve businesses and create long-term value. Since 2000, Comvest has invested more than $1.5 billion of capital in over 105 public and private companies.  For more information, please visit www.comvest.com. FastMed Contact:

MedVantx Contact: Jason A. Williams

JD Haldeman (919) 550-0821

(858) 625-2990 ext. 130 j.williams@fastmed.com

JD.Haldeman@MedVantx.com


'/>"/>
SOURCE MedVantx, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. European Thrombosis Therapeutics Market is Experiencing an Urgent Need for Enhanced Products, Says Frost & Sullivan
2. CSL Behring Announces FDA Filing of Biologics License Application for 4-Factor PCC for Urgent Reversal of Vitamin K Antagonist Anticoagulant Therapy
3. PM Pediatrics Brings Its Award-Winning Pediatric Urgent Care To Downtown Brooklyn
4. Frost & Sullivan Determines a Real and Urgent Need for Novel Cancer Diagnostics Tests
5. MedVantx MedStart™ Solves Problem Highlighted in Study Published in Journal of the American Board of Family Medicine - Expired Medications in Physician Office Sample Closets
6. MedVantx Names New VP Employer Solutions and Workplace Health
7. MedVantx Pharmacy Services Receives Coveted VIPPS Accreditation (Verified Internet Pharmacy Practice Sites)
8. MedVantx Achieves Significant Milestone of Providing Over $600 Million of Specialty Pharmacy Prescription Medications to Consumers
9. Pressure BioSciences, Inc. and Target Discovery, Inc. Expand Strategic License Agreement and Collaboration Supporting TDIs Planned Offering of Personalized Medicine Clinical Diagnostic Services
10. Two Top Notch Cadaver Workshops Offered by joimax® in April
11. Varian Medical Systems and Siemens Healthcare Announce Global Collaboration to Advance Clinical Capabilities and Offerings in Radiotherapy and Radiosurgery
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/8/2016)... , Dec. 8, 2016  Eli Lilly and ... results of its phase 3 EXPEDITION3 trial at the ... meeting. As previously disclosed, solanezumab did not meet the ... of solanezumab initiated in people with mild dementia due ... regulatory submissions for solanezumab for the treatment of mild ...
(Date:12/8/2016)... de dezembro de 2016  A Mederi Therapeutics Inc . anunciou aprovação ... não cirúrgico para a doença do refluxo gastroesofágico (DRGE). Foto -  ... ... Live Stretta procedure performed and broadcast during the Chinese ... Union Hospital , ...
(Date:12/8/2016)... Pa. , Dec. 8, 2016  Pennsylvania ... Secretary of Drug and Alcohol Programs Gary ... and insomnia medications, known as benzodiazepines, developed with ... "Benzodiazepines are medications that are frequently prescribed ... when they are used with opioid pain medications, ...
Breaking Medicine Technology:
(Date:12/9/2016)... ... December 09, 2016 , ... Sober College, ... with the grand opening of the Sober College Robert Pfeifer Memorial Learning Center ... December 2-3, and was attended by an overwhelming amount of alumni, family, colleagues ...
(Date:12/9/2016)... , ... December 09, 2016 , ... "I had a ... inventor from Winchester, Va. "I thought that if the nebulizer had a more child-friendly ... than fearing them." , He developed the patent-pending NEBY to avoid the need to ...
(Date:12/8/2016)... , ... December 08, 2016 , ... ... Franchising Company LLC, announced the first national #QuackGivesBack campaign which supported local ... “This was our first franchise-wide Quack Gives Back initiative, and we’re ...
(Date:12/8/2016)... ... December 08, 2016 , ... With the increasing demand for dental implants, the ... (WIYM) campaign to inform dentists and patients about the safety issues related to dental ... market in the U.S. is projected to reach $6.4 billion in 2018 with more ...
(Date:12/8/2016)... ... 2016 , ... Catalent Pharma Solutions, the leading global provider ... products, today announced that it had joined the Pharmaceutical Supply Chain Initiative (PSCI). ... unite pharmaceutical and healthcare companies that share a vision of better, social, environmental ...
Breaking Medicine News(10 mins):